- Marketwired•25 days ago
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis , ...
- Capital Cube•2 months ago
Categories: Yahoo Finance Get free summary analysis Nutra Pharma Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Nutra Pharma Corp. – Sangamo BioSciences, Inc., Albany Molecular Research, Inc., USANA Health Sciences, Inc. and Natural Alternatives International, Inc. (SGMO-US, AMRI-US, USNA-US and NAII-US) that have also ... Read more (Read more...)
- Marketwired•last year
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis , ...
NPHC : Summary for NUTRA PHARMA CORP USD0.001(POST - Yahoo Finance
Nutra Pharma Corp. (NPHC)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.01 - 0.01|
|52 Week Range||0.01 - 0.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.65|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|